BRAF and gastric cancer: Recently, Lee et al.20 reported observing a 979 AA SND1-BRAF fusion transcript between exons 1–16 of SND1 providing the promoter and exons 9–18 of BRAF in a gastric cancer cell line after treatment with MET inhibitor and provides the driver of the overexpressed BRAF in a fusion.